miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2. (Q39404993)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 January 2012
edit
Language Label Description Also known as
English
miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2.
scientific article published on 26 January 2012

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit